Malherbe F, Nel D, Molabe H, Cairncross L, Roodt L. Palpable breast lumps: an age-based approach to evaluation and diagnosis. S Afr Fam Pract. 2004;2022(64):e1–5. https://doi.org/10.4102/safp.v64i1.5571.

Article  Google Scholar 

Klein S. Evaluation of palpable breast masses. Am Fam Physician. 2005;71:1731–8.

Google Scholar 

Steinberg JL, Trudeau ME, Ryder DE, et al. Combined fine-needle aspiration, physical examination, and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer. Can J Surg. 1996;39:302–11.

CAS  Google Scholar 

Jensen A, Rank F, Dyreborg U, et al. Performance of combined clinical mammography and needle biopsy: a nationwide study from Denmark. Apmis. 2006;114:884–92. https://doi.org/10.1111/j.1600-0463.2006.apm_408.x.

Article  Google Scholar 

Lehman CD, Lee AY, Lee CI. Imaging management of palpable breast abnormalities. AJR Am J Roentgenol. 2014;203:1142–53. https://doi.org/10.2214/ajr.14.12725.

Article  Google Scholar 

Wai CJ, Al-Mubarak G, Homer MJ, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013;20:850–5. https://doi.org/10.1245/s10434-012-2710-y.

Article  Google Scholar 

Leung SE, Ben-Nachum I, Kornecki A. New palpable breast lump with recent negative mammogram: is repeat mammography necessary? AJR Am J Roentgenol. 2016;207:200–4. https://doi.org/10.2214/ajr.15.14799.

Article  Google Scholar 

Brown AL, Phillips J, Slanetz PJ, et al. Clinical value of mammography in the evaluation of palpable breast lumps in women 30 years old and older. AJR Am J Roentgenol. 2017;209:935–42. https://doi.org/10.2214/ajr.16.17088.

Article  Google Scholar 

Radiology ACo. ACR Appropriateness Criteria Palpable Breast Masses. 2022. https://acsearch.acr.org/docs/69495/narrative/.

Network NCC. Breast Cancer Screening and Diagnosis. 2022. https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdf.

Harvey JA, Mahoney MC, Newell MS, et al. ACR appropriateness criteria palpable breast masses. J Am Coll Radiol. 2016;13:e31–42. https://doi.org/10.1016/j.jacr.2016.09.022.

Article  Google Scholar 

Dennis MA, Parker SH, Klaus AJ, Stavros AT, Kaske TI, Clark SB. Breast biopsy avoidance: the value of normal mammograms and normal sonograms in the setting of a palpable lump. Radiology. 2001;219:186–91. https://doi.org/10.1148/radiology.219.1.r01ap35186.

Article  CAS  Google Scholar 

Moy L, Slanetz PJ, Moore R, et al. Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology. 2002;225:176–81. https://doi.org/10.1148/radiol.2251010999.

Article  Google Scholar 

Shetty MK, Shah YP. Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast. J Ultrasound Med. 2002; 21:1211–6; quiz 1217–9. https://doi.org/10.7863/jum.2002.21.11.1211.

Chan CH, Coopey SB, Freer PE, Hughes KS. False-negative rate of combined mammography and ultrasound for women with palpable breast masses. Breast Cancer Res Treat. 2015;153:699–702. https://doi.org/10.1007/s10549-015-3557-2.

Article  Google Scholar 

Soo MS, Rosen EL, Baker JA, Vo TT, Boyd BA. Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol. 2001;177:1167–70. https://doi.org/10.2214/ajr.177.5.1771167.

Article  CAS  Google Scholar 

Ajkay N, Bloomquist EV, Martin RC II, Frazier TG, Barrio AV. Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities. Surgery. 2015;158:946–52; discussion 952–3. https://doi.org/10.1016/j.surg.2015.07.009.

Sundara Rajan S, White J, Peckham-Cooper A, Lane S, Lansdown M. Management of palpable but radiologically occult breast abnormalities. Acta Cytol. 2012;56:266–70. https://doi.org/10.1159/000337435.

Article  Google Scholar 

Gumus H, Gumus M, Mills P, et al. Clinically palpable breast abnormalities with normal imaging: is clinically guided biopsy still required? Clin Radiol. 2012;67:437–40. https://doi.org/10.1016/j.crad.2011.10.010.

Article  CAS  Google Scholar 

Olsen ML, Morton MJ, Stan DL, Pruthi S. Is there a role for magnetic resonance imaging in diagnosing palpable breast masses when mammogram and ultrasound are negative? J Womens Health Larchmt. 2012;21:1149–54. https://doi.org/10.1089/jwh.2012.3735.

Article  Google Scholar 

Yalniz C, Campbell D, Le-Petross C, et al. The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings. Breast J. 2020;26:1289–95. https://doi.org/10.1111/tbj.13793.

Article  Google Scholar 

Amitai Y, Menes TS, Weinstein I, Filyavich A, Yakobson I, Golan O. What is the yield of breast MRI in the assessment of palpable breast findings? Clin Radiol. 2017;72:930–5. https://doi.org/10.1016/j.crad.2017.06.120.

Article  CAS  Google Scholar 

Witek-Janusek L, Gabram S, Mathews HL. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology. 2007;32:22–35. https://doi.org/10.1016/j.psyneuen.2006.09.011.

Article  CAS  Google Scholar 

Humphrey KL, Lee JM, Donelan K, et al. Percutaneous breast biopsy: effect on short-term quality of life. Radiology. 2014;270:362–8. https://doi.org/10.1148/radiol.13130865.

Article  Google Scholar 

Fazeli S, Snyder BS, Gareen IF, et al. Patient-reported testing burden of breast magnetic resonance imaging among women with ductal carcinoma in situ: an ancillary study of the ECOG-ACRIN Cancer Research Group (E4112). JAMA Netw Open. 2021;4:e2129697. https://doi.org/10.1001/jamanetworkopen.2021.29697.

Article  Google Scholar 

Pan IW, Oeffinger KC, Shih YT. Cost-sharing and out-of-pocket cost for women who received MRI for breast cancer screening. J Natl Cancer Inst. 2022;114:254–62. https://doi.org/10.1093/jnci/djab150.

Article  Google Scholar 

Fine-needle aspiration biopsy, including fluoroscopic guidance; first lesion. Retrieved 25 January 2025 at https://www.medicare.gov/procedure-price-lookup/cost/10007/.

Ginsburg O, Yip CH, Brooks A, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126(Suppl 10):2379–93. https://doi.org/10.1002/cncr.32887.

Article  Google Scholar 

Graf O, Helbich TH, Fuchsjaeger MH, et al. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology. 2004;233:850–6. https://doi.org/10.1148/radiol.2333031845.

Article  Google Scholar 

Qaseem A, Lin JS, Mustafa RA, et al. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med. 2019;170:547–60. https://doi.org/10.7326/m18-2147.

Article  Google Scholar 

American Cancer Society Recommendations for the Early Detection of Breast Cancer. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html.